View in EDS PDF Full Text

A Phase 1 study of UCN-01 in combination with irinotecan in patients with resistant solid tumor malignancies.

Saved in:
Bibliographic Details
Title: A Phase 1 study of UCN-01 in combination with irinotecan in patients with resistant solid tumor malignancies.
Authors: Fracasso PM; Department of Internal Medicine, Alvin J. Siteman Cancer Center and Washington University School of Medicine, St Louis, MO, USA. fracasso@virginia.edu, Williams KJ, Chen RC, Picus J, Ma CX, Ellis MJ, Tan BR, Pluard TJ, Adkins DR, Naughton MJ, Rader JS, Arquette MA, Fleshman JW, Creekmore AN, Goodner SA, Wright LP, Guo Z, Ryan CE, Tao Y, Soares EM, Cai SR, Lin L, Dancey J, Rudek MA, McLeod HL, Piwnica-Worms H
Source: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2011 Jun; Vol. 67 (6), pp. 1225-37. Date of Electronic Publication: 2010 Aug 08.
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 20694727
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A Phase 1 study of UCN-01 in combination with irinotecan in patients with resistant solid tumor malignancies.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Fracasso+PM%22">Fracasso PM</searchLink>; Department of Internal Medicine, Alvin J. Siteman Cancer Center and Washington University School of Medicine, St Louis, MO, USA. fracasso@virginia.edu<br /><searchLink fieldCode="AU" term="%22Williams+KJ%22">Williams KJ</searchLink><br /><searchLink fieldCode="AU" term="%22Chen+RC%22">Chen RC</searchLink><br /><searchLink fieldCode="AU" term="%22Picus+J%22">Picus J</searchLink><br /><searchLink fieldCode="AU" term="%22Ma+CX%22">Ma CX</searchLink><br /><searchLink fieldCode="AU" term="%22Ellis+MJ%22">Ellis MJ</searchLink><br /><searchLink fieldCode="AU" term="%22Tan+BR%22">Tan BR</searchLink><br /><searchLink fieldCode="AU" term="%22Pluard+TJ%22">Pluard TJ</searchLink><br /><searchLink fieldCode="AU" term="%22Adkins+DR%22">Adkins DR</searchLink><br /><searchLink fieldCode="AU" term="%22Naughton+MJ%22">Naughton MJ</searchLink><br /><searchLink fieldCode="AU" term="%22Rader+JS%22">Rader JS</searchLink><br /><searchLink fieldCode="AU" term="%22Arquette+MA%22">Arquette MA</searchLink><br /><searchLink fieldCode="AU" term="%22Fleshman+JW%22">Fleshman JW</searchLink><br /><searchLink fieldCode="AU" term="%22Creekmore+AN%22">Creekmore AN</searchLink><br /><searchLink fieldCode="AU" term="%22Goodner+SA%22">Goodner SA</searchLink><br /><searchLink fieldCode="AU" term="%22Wright+LP%22">Wright LP</searchLink><br /><searchLink fieldCode="AU" term="%22Guo+Z%22">Guo Z</searchLink><br /><searchLink fieldCode="AU" term="%22Ryan+CE%22">Ryan CE</searchLink><br /><searchLink fieldCode="AU" term="%22Tao+Y%22">Tao Y</searchLink><br /><searchLink fieldCode="AU" term="%22Soares+EM%22">Soares EM</searchLink><br /><searchLink fieldCode="AU" term="%22Cai+SR%22">Cai SR</searchLink><br /><searchLink fieldCode="AU" term="%22Lin+L%22">Lin L</searchLink><br /><searchLink fieldCode="AU" term="%22Dancey+J%22">Dancey J</searchLink><br /><searchLink fieldCode="AU" term="%22Rudek+MA%22">Rudek MA</searchLink><br /><searchLink fieldCode="AU" term="%22McLeod+HL%22">McLeod HL</searchLink><br /><searchLink fieldCode="AU" term="%22Piwnica-Worms+H%22">Piwnica-Worms H</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227806519%22">Cancer chemotherapy and pharmacology</searchLink> [Cancer Chemother Pharmacol] 2011 Jun; Vol. 67 (6), pp. 1225-37. <i>Date of Electronic Publication: </i>2010 Aug 08.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>7806519 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-0843 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203445704%22">03445704 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Chemother Pharmacol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=20694727
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s00280-010-1410-1
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1225
    Titles:
      – TitleFull: A Phase 1 study of UCN-01 in combination with irinotecan in patients with resistant solid tumor malignancies.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Fracasso PM
      – PersonEntity:
          Name:
            NameFull: Williams KJ
      – PersonEntity:
          Name:
            NameFull: Chen RC
      – PersonEntity:
          Name:
            NameFull: Picus J
      – PersonEntity:
          Name:
            NameFull: Ma CX
      – PersonEntity:
          Name:
            NameFull: Ellis MJ
      – PersonEntity:
          Name:
            NameFull: Tan BR
      – PersonEntity:
          Name:
            NameFull: Pluard TJ
      – PersonEntity:
          Name:
            NameFull: Adkins DR
      – PersonEntity:
          Name:
            NameFull: Naughton MJ
      – PersonEntity:
          Name:
            NameFull: Rader JS
      – PersonEntity:
          Name:
            NameFull: Arquette MA
      – PersonEntity:
          Name:
            NameFull: Fleshman JW
      – PersonEntity:
          Name:
            NameFull: Creekmore AN
      – PersonEntity:
          Name:
            NameFull: Goodner SA
      – PersonEntity:
          Name:
            NameFull: Wright LP
      – PersonEntity:
          Name:
            NameFull: Guo Z
      – PersonEntity:
          Name:
            NameFull: Ryan CE
      – PersonEntity:
          Name:
            NameFull: Tao Y
      – PersonEntity:
          Name:
            NameFull: Soares EM
      – PersonEntity:
          Name:
            NameFull: Cai SR
      – PersonEntity:
          Name:
            NameFull: Lin L
      – PersonEntity:
          Name:
            NameFull: Dancey J
      – PersonEntity:
          Name:
            NameFull: Rudek MA
      – PersonEntity:
          Name:
            NameFull: McLeod HL
      – PersonEntity:
          Name:
            NameFull: Piwnica-Worms H
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2011 Jun
              Type: published
              Y: 2011
          Identifiers:
            – Type: issn-electronic
              Value: 1432-0843
          Numbering:
            – Type: volume
              Value: 67
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Cancer chemotherapy and pharmacology
              Type: main
ResultId 1